Siga Technologies Target of Unusually Large Options Trading (NASDAQ:SIGA)
by Mitch Edgeman · The Markets DailySiga Technologies Inc. (NASDAQ:SIGA – Get Free Report) saw some unusual options trading on Wednesday. Investors bought 1,200 call options on the company. This is an increase of 1,438% compared to the typical volume of 78 call options.
Siga Technologies Price Performance
Shares of NASDAQ SIGA opened at $6.85 on Thursday. Siga Technologies has a 1-year low of $4.95 and a 1-year high of $9.62. The business’s 50 day moving average is $6.45 and its two-hundred day moving average is $7.45. The stock has a market capitalization of $490.53 million, a P/E ratio of 6.72 and a beta of 0.98.
Siga Technologies (NASDAQ:SIGA – Get Free Report) last announced its earnings results on Thursday, November 6th. The company reported ($0.09) EPS for the quarter. The company had revenue of $2.62 million during the quarter. Siga Technologies had a return on equity of 35.23% and a net margin of 43.22%. As a group, equities research analysts anticipate that Siga Technologies will post 1.04 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the company. EP Wealth Advisors LLC raised its stake in shares of Siga Technologies by 44.1% in the first quarter. EP Wealth Advisors LLC now owns 20,018 shares of the company’s stock valued at $110,000 after acquiring an additional 6,131 shares during the period. Jane Street Group LLC grew its holdings in Siga Technologies by 138.4% during the 1st quarter. Jane Street Group LLC now owns 114,147 shares of the company’s stock valued at $626,000 after purchasing an additional 66,265 shares during the last quarter. Strs Ohio purchased a new stake in Siga Technologies in the 1st quarter worth about $165,000. Wealth Enhancement Advisory Services LLC purchased a new stake in Siga Technologies in the 2nd quarter worth about $394,000. Finally, Kapitalo Investimentos Ltda bought a new stake in Siga Technologies in the second quarter worth about $183,000. Institutional investors own 55.40% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on SIGA. Wall Street Zen cut Siga Technologies from a “strong-buy” rating to a “hold” rating in a report on Saturday, November 15th. Weiss Ratings cut shares of Siga Technologies from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.
View Our Latest Analysis on Siga Technologies
Siga Technologies Company Profile
Siga Technologies, Inc (NASDAQ: SIGA) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of medical countermeasures for public health emergencies and biological threats. The company’s flagship product, TPOXX® (tecovirimat), is the first and only antiviral approved by the U.S. Food and Drug Administration for the treatment of smallpox. Siga has entered into procurement and development contracts with U.S. government agencies, including the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense, to supply TPOXX® for the Strategic National Stockpile.
Founded in 2002, Siga has built a pipeline of therapies targeting high-consequence pathogens such as smallpox, plague and other potential biothreat agents.